|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0205 USD | +3.39% |
|
+6.77% | -66.61% |
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.18M 3.66M 3.4M 3.12M 5.88M 403M 5.97M 40.46M 15.84M 197M 15.67M 15.34M 681M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.89M 5.16M 4.79M 4.41M 8.3M 569M 8.42M 57.11M 22.35M 278M 22.12M 21.65M 961M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +3.39% | ||
| 1 week | +6.77% | ||
| Current month | -15.64% | ||
| 1 month | -8.89% | ||
| 3 months | -40.41% | ||
| 6 months | -53.41% | ||
| Current year | -66.61% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.03 |
| Current year | 0.02 | | 0.1 |
| 1 year | 0.02 | | 0.1 |
| 3 years | 0.02 | | 0.1 |
| 5 years | 0.02 | | 0.36 |
| 10 years | 0.02 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.39% | +6.77% | -48.36% | -58.42% | 4.18M | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | |
| +2.92% | +2.96% | +30.65% | +24.83% | 326B | |
| -0.64% | +0.83% | +33.46% | +36.87% | 293B | |
| -1.08% | -0.81% | +17.35% | +16.20% | 264B | |
| -1.48% | -6.46% | -29.07% | -42.89% | 216B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | +0.34% | +1.69% | +17.95% | +37.22% | 355.74B | |
| Weighted average by Cap. | -0.07% | +1.47% | +35.01% | +72.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.76M 12.77M 11.74M 22.12M 1.52B 22.45M 152M 59.56M 742M 58.95M 57.68M 2.56B | 13.79M 12.08M 11.22M 10.31M 19.42M 1.33B 19.71M 134M 52.3M 651M 51.76M 50.65M 2.25B |
| Net income | -2.39M -2.1M -1.95M -1.79M -3.37M -231M -3.42M -23.2M -9.08M -113M -8.99M -8.79M -390M | -958K -839K -779K -716K -1.35M -92.44M -1.37M -9.28M -3.63M -45.23M -3.6M -3.52M -156M |
| Net Debt | 325K 285K 264K 243K 458K 31.36M 464K 3.15M 1.23M 15.35M 1.22M 1.19M 53.01M | 1.72M 1.51M 1.4M 1.28M 2.42M 166M 2.46M 16.65M 6.52M 81.12M 6.45M 6.31M 280M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | $0.0205 | +3.39% | 305,777 |
| 21/07/26 | $0.0198 | +10.00% | 525,767 |
| 20/07/26 | $0.0180 | -10.00% | 528,130 |
| 17/07/26 | $0.0200 | -2.44% | 1,039,549 |
| 16/07/26 | $0.0205 | +6.99% | 262,469 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
